1. Home
  2. ELF vs PTCT Comparison

ELF vs PTCT Comparison

Compare ELF & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo e.l.f. Beauty Inc.

ELF

e.l.f. Beauty Inc.

N/A

Current Price

$111.51

Market Cap

6.7B

ML Signal

N/A

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

N/A

Current Price

$60.98

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELF
PTCT
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.5B
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
ELF
PTCT
Price
$111.51
$60.98
Analyst Decision
Buy
Buy
Analyst Count
18
15
Target Price
★ $114.94
$97.80
AVG Volume (30 Days)
★ 1.2M
946.0K
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 264.48
EPS
★ 1.12
0.34
Revenue
★ $1,636,472,000.00
$264,734,000.00
Revenue This Year
$20.90
N/A
Revenue Next Year
$8.85
$8.55
P/E Ratio
$101.21
★ $71.73
Revenue Growth
24.59
★ 36.19
52 Week Low
$48.82
$58.80
52 Week High
$123.07
$90.87

Technical Indicators

Market Signals
Indicator
ELF
PTCT
Relative Strength Index (RSI) 56.42 43.39
Support Level $90.39 $58.80
Resistance Level $118.29 $63.74
Average True Range (ATR) 4.02 2.31
MACD -0.37 0.34
Stochastic Oscillator 43.62 30.89

Price Performance

Historical Comparison
ELF
PTCT

About ELF e.l.f. Beauty Inc.

e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: